ArticleBMC medical research methodology2026
Sample size and power analysis for ROC AUC differences in diagnostic tests: a methodological evaluation of the Obuchowski-McClish and Hanley-McNeil methods.
Article in BMC medical research methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Molecular-Based Risk Prediction Models for Recurrence After Curative Treatment of Early-Stage Lung Cancer: A Systematic Review and Meta-Analysis.Thoracic cancer · 2026Pooled it
- Quantitative method comparison in non-targeted analysis using cascade classification.Analytical and bioanalytical chemistry · 2026Article
- Predictive modeling and clinical decision tools for risk stratification in steatotic liver disease.Clinical and molecular hepatology · 2026Review
- A Systematic Evaluation of Cohort Selection Criteria and Their Impact on Machine Learning Model Performance and Demographic Disparities in COVID-19 Outcomes: Cohort Study.JMIR formative research · 2026Article
- Diagnostic capability of ganglion cell complex thickness using spectral domain optical coherence tomography in glaucoma.BMC ophthalmology · 2026Observational
- Comparison of the diagnostic performance of alanine aminotransferase and ultrasonography for discrimination of liver biopsy proven metabolic associated steatotic liver disease: a ROC curve analysis.BMC endocrine disorders · 2026Article
- Comparative Evaluation of Machine Learning and Conventional Material Decomposition Algorithms for Spectral Chest Radiography Using a CdTe Photon-Counting Detector.Sensors (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSample size determination for area under the curve (AUC) comparisons in diagnostic accuracy studies requires the consideration of multiple methodological parameters. The type of diagnostic test, the nature of the data (discrete or continuous), the correlation structure between tests, and the degree of AUC differences all influence optimal study design and planning. To address these factors, this study provides comprehensive sample size and power calculations for comparing AUCs between diagnostic tests across clinically relevant scenarios.
methodsWe conducted a comprehensive evaluation of sample size and power analysis for AUC comparisons under varying correlation levels (ρ = 0.30, 0.50, 0.80), data types (discrete vs. continuous), and AUC differences (ΔAUC = 0.02–0.10). The Obuchowski–McClish method was applied for discrete data, and the Hanley–McNeil approach was applied for continuous data, assuming balanced case-control allocation and two-sided testing (α = 0.05). Sample sizes were calculated to achieve 80% statistical power based on established methodological approaches and adjusted for a 20% anticipated attrition rate. Power curves were generated to illustrate the relationship between sample size and statistical power across the evaluated scenarios.
resultsThe required sample sizes varied substantially across scenarios, ranging from 36 − 3,709 participants per group to achieve 80% power. The degree of difference in the area under the curve (AUC) was the primary determinant: ΔAUC = 0.02 required 909-3,709 participants, whereas a ΔAUC = 0.10 required only 36–142 participants. Inter-test correlation also had a marked impact on efficiency, with a strong correlation (ρ = 0.8) reducing sample sizes by 49% in discrete models and 68% in continuous models compared with a weak correlation (ρ = 0.3). Continuous data models consistently outperformed discrete models, requiring 24–53% fewer participants across all the scenarios. The most demanding scenario (ΔAUC = 0.02, discrete data, ρ = 0.3) required 3,709 participants per group, whereas the most efficient scenario (ΔAUC = 0.10, continuous data, ρ = 0.8) required only 36 participants, representing a 103-fold difference.
conclusionsMethodological choices lead to substantial variations in sample size requirements for diagnostic accuracy studies. Optimal parameter selection, particularly the use of continuous data models and accounting for strong inter-test correlations, can reduce the required sample sizes by up to 68% compared with suboptimal combinations. These results provide evidence-based guidance for efficient planning of diagnostic accuracy studies and underscore the critical importance of methodological considerations in study design optimization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.